Proto Script Pharmaceutical Stock Analysis
| PSCR Stock | USD 0.0001 0.00 0.00% |
Proto Script Pharmac holds a debt-to-equity ratio of 0.62. Proto Script's financial risk is the risk to Proto Script stockholders that is caused by an increase in debt.
Asset vs Debt
Equity vs Debt
Proto Script's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Proto Script's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Proto Pink Sheet's retail investors understand whether an upcoming fall or rise in the market will negatively affect Proto Script's stakeholders.
For many companies, including Proto Script, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Proto Script Pharmaceutical, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Proto Script's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Given that Proto Script's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Proto Script is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Proto Script to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Proto Script is said to be less leveraged. If creditors hold a majority of Proto Script's assets, the Company is said to be highly leveraged.
Proto Script Pharmaceutical is overvalued with Real Value of 9.6E-5 and Hype Value of 1.06E-4. The main objective of Proto Script pink sheet analysis is to determine its intrinsic value, which is an estimate of what Proto Script Pharmaceutical is worth, separate from its market price. There are two main types of Proto Script's stock analysis: fundamental analysis and technical analysis.
The Proto Script pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Proto |
Proto Pink Sheet Analysis Notes
The company recorded a loss per share of 0.06. Proto Script Pharmac had not issued any dividends in recent years. The entity had 10:1 split on the 13th of October 2016. Proto Script Pharmaceutical Corp. engages in the repair and rental of power wheelchairs and scooters. Proto Script Pharmaceutical Corp. was founded in 2001 and is headquartered in Rancho Cucamonga, California. Proto Script operates under Specialty Business Services classification in the United States and is traded on OTC Exchange.The quote for Proto Script Pharmaceutical is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Proto Script Pharmaceutical contact Michelle Rico at 855-476-7679 or learn more at https://www.psphomecare.com.Proto Script Pharmac Investment Alerts
| Proto Script Pharmac generated a negative expected return over the last 90 days | |
| Proto Script Pharmac has high historical volatility and very poor performance | |
| Proto Script Pharmac has some characteristics of a very speculative penny stock | |
| Proto Script Pharmac has a very high chance of going through financial distress in the upcoming years | |
| Proto Script Pharmaceutical currently holds 372.75 K in liabilities with Debt to Equity (D/E) ratio of 0.62, which is about average as compared to similar companies. Proto Script Pharmac has a current ratio of 0.11, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Proto Script until it has trouble settling it off, either with new capital or with free cash flow. So, Proto Script's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Proto Script Pharmac sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Proto to invest in growth at high rates of return. When we think about Proto Script's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 788.96 K. Net Loss for the year was (7.18 M) with profit before overhead, payroll, taxes, and interest of 564.47 K. |
Proto Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 90. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Proto Script's market, we take the total number of its shares issued and multiply it by Proto Script's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 16th of February 2026, Proto Script holds the Risk Adjusted Performance of (0.09), coefficient of variation of (793.73), and Variance of 70.55. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Proto Script, as well as the relationship between them. Please check Proto Script Pharmac market risk adjusted performance and total risk alpha to decide if Proto Script Pharmac is priced some-what accurately, providing market reflects its current price of 1.0E-4 per share. As Proto Script Pharmac appears to be a penny stock we also advise to check out its information ratio numbers.Proto Script Pharmac Price Movement Analysis
java.lang.NullPointerException: Cannot invoke "java.lang.Number.intValue()" because the return value of "sun.invoke.util.ValueConversions.primitiveConversion(sun.invoke.util.Wrapper, Object, boolean)" is null. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Proto Script middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Proto Script Pharmac. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Proto Script Outstanding Bonds
Proto Script issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Proto Script Pharmac uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Proto bonds can be classified according to their maturity, which is the date when Proto Script Pharmaceutical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US743756AB40 Corp BondUS743756AB40 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Proto Script Predictive Daily Indicators
Proto Script intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Proto Script pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0E-4 | |||
| Day Typical Price | 1.0E-4 |
Proto Script Forecast Models
Proto Script's time-series forecasting models are one of many Proto Script's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Proto Script's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.Proto Script Pharmac Debt to Cash Allocation
Many companies such as Proto Script, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Proto Script Pharmaceutical currently holds 372.75 K in liabilities with Debt to Equity (D/E) ratio of 0.62, which is about average as compared to similar companies. Proto Script Pharmac has a current ratio of 0.11, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Proto Script until it has trouble settling it off, either with new capital or with free cash flow. So, Proto Script's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Proto Script Pharmac sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Proto to invest in growth at high rates of return. When we think about Proto Script's use of debt, we should always consider it together with cash and equity.Proto Script Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Proto Script's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Proto Script, which in turn will lower the firm's financial flexibility.Proto Script Corporate Bonds Issued
About Proto Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Proto Script prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Proto shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Proto Script. By using and applying Proto Pink Sheet analysis, traders can create a robust methodology for identifying Proto entry and exit points for their positions.
Proto Script Pharmaceutical Corp. engages in the repair and rental of power wheelchairs and scooters. Proto Script Pharmaceutical Corp. was founded in 2001 and is headquartered in Rancho Cucamonga, California. Proto Script operates under Specialty Business Services classification in the United States and is traded on OTC Exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Proto Script to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Funds Screener Now
Funds ScreenerFind actively-traded funds from around the world traded on over 30 global exchanges |
| All Next | Launch Module |
Additional Tools for Proto Pink Sheet Analysis
When running Proto Script's price analysis, check to measure Proto Script's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Proto Script is operating at the current time. Most of Proto Script's value examination focuses on studying past and present price action to predict the probability of Proto Script's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Proto Script's price. Additionally, you may evaluate how the addition of Proto Script to your portfolios can decrease your overall portfolio volatility.